Literature DB >> 11430620

Detection of uveal melanoma by optometrists in the United Kingdom.

B Damato1.   

Abstract

In the United Kingdom, most uveal melanomas are detected by optometrists. Prospectively collected data on patients with uveal melanoma presenting to optometrists were analysed retrospectively to determine: (a) the proportion of patients who were asymptomatic at the time of tumour detection, (b) the proportion of symptomatic patients reporting that their tumour was missed at their initial presentation and (c) the clinical features related to immediate tumour detection. The 223 patients had a mean age of 59.7 years, a mean tumour diameter of 11.3 mm and a mean tumour thickness of 4.6 mm. Symptoms were present in 122 patients (55%) and were associated with large tumour size (p < 0.0001) and male gender (p = 0.003), with more males tending to have a large tumour (p = 0.004). Seventy-nine percent of symptomatic patients reported that their tumour was detected at their first visit. Failure of tumour detection in symptomatic patients was associated with absence of tumour extension posterior to equator (p < 0.0001).

Entities:  

Mesh:

Year:  2001        PMID: 11430620     DOI: 10.1046/j.1475-1313.2001.00595.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  11 in total

1.  Differences in uveal melanomas between men and women from the British Isles.

Authors:  B E Damato; S E Coupland
Journal:  Eye (Lond)       Date:  2011-11-11       Impact factor: 3.775

Review 2.  Primary care and ophthalmology in the United Kingdom.

Authors:  S F Riad; J K G Dart; R J Cooling
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

3.  Parthenolide inhibits the proliferation and induces the apoptosis of human uveal melanoma cells.

Authors:  Song-Tian Che; Li Bie; Xu Li; Hui Qi; Peng Yu; Ling Zuo
Journal:  Int J Ophthalmol       Date:  2019-10-18       Impact factor: 1.779

4.  Mode of presentation and time to treatment of uveal melanoma in Finland.

Authors:  S Eskelin; T Kivelä
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

Review 5.  Does ocular treatment of uveal melanoma influence survival?

Authors:  B Damato
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

6.  Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature.

Authors:  Yolanda Piña; Colleen M Cebulla; Timothy G Murray; Armando Alegret; Sander R Dubovy; Hinda Boutrid; William Feuer; Lejla Mutapcic; Maria-Elena Jockovich
Journal:  Ophthalmic Res       Date:  2009-03-26       Impact factor: 2.892

Review 7.  The biology of uveal melanoma.

Authors:  Adriana Amaro; Rosaria Gangemi; Francesca Piaggio; Giovanna Angelini; Gaia Barisione; Silvano Ferrini; Ulrich Pfeffer
Journal:  Cancer Metastasis Rev       Date:  2017-03       Impact factor: 9.264

8.  Reflections on a Health Psychology Service for Patients with Uveal Melanoma: The Challenge of Psychological Screening and Intervention When Distress is 'Normal'.

Authors:  Laura Hope-Stone; Janice Ablett; Peter Salmon
Journal:  J Clin Psychol Med Settings       Date:  2019-12

Review 9.  Future perspectives of uveal melanoma blood based biomarkers.

Authors:  Aaron B Beasley; Fred K Chen; Timothy W Isaacs; Elin S Gray
Journal:  Br J Cancer       Date:  2022-02-21       Impact factor: 9.075

10.  Epidemiological Study of Uveal Melanoma from US Surveillance, Epidemiology, and End Results Program (2010-2015).

Authors:  Yufeng Xu; Lixia Lou; Yijie Wang; Qi Miao; Kai Jin; Menglu Chen; Juan Ye
Journal:  J Ophthalmol       Date:  2020-02-19       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.